[Glucose intolerance induced by interferon therapy].
Sasaoka
Toshiyasu
T
Department of Clinical Pharmacology, Toyama Medical and Pharmaceutical University.
D001327:Autoimmune Diseases / Q000139:chemically induced; D003922:Diabetes Mellitus, Type 1 / Q000139:chemically induced; D005130:Eye Hemorrhage / Q000139:chemically induced; D018149:Glucose Intolerance / Q000139:chemically induced*; D006801:Humans; D007333:Insulin Resistance; D007372:Interferons / Q000009:adverse effects*
D007372:Interferons